Urinary bladder cancer
MONDO:0001187A primary or metastatic malignant neoplasm involving the bladder.
Also known as: tumor of the bladder, tumour of the bladder, bladder cancer, somatic, cancer of urinary bladder, malignant bladder neoplasm, malignant bladder tumor, malignant bladder tumour, malignant neoplasm of bladder
3396 clinical trials for this condition and its sub-types, 39 tagged with Urinary bladder cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Urinary bladder cancer
-
Urinary bladder carcinoma 392 trials · 669 incl. sub-types
9 sub-types
- Bladder transitional cell carcinoma 130 trials · 408 incl. sub-types Sub-types →
- Superficial urinary bladder carcinoma 76 trials
- Stage IVb bladder cancer 39 trials
- Urinary bladder small cell neuroendocrine carcinoma 9 trials
- Bladder adenocarcinoma 5 trials · 8 incl. sub-types Sub-types →
- Bladder urachal carcinoma 3 trials · 6 incl. sub-types Sub-types →
- Bladder squamous cell carcinoma 5 trials Sub-types →
- Bladder small cell carcinoma 0 trials
- Childhood bladder carcinoma 0 trials
-
Urachus cancer 3 trials · 6 incl. sub-types
1 sub-type
- Bladder urachal adenocarcinoma 5 trials
-
Bladder dome cancer 0 trials
2 sub-types
- Bladder trigone cancer 0 trials
- Ureteric orifice cancer 0 trials
-
Bladder lateral wall cancer 0 trials
-
Bladder lymphoma 0 trials
-
Bladder neck cancer 0 trials
-
Bladder sarcoma 0 trials
-
Urinary bladder anterior wall cancer 0 trials
Most studied deeper sub-types
-
Can a pill target cancers with a specific gene flaw?
Disease control Not yet recruitingThis phase II trial tests an experimental drug called TR115 in people with advanced solid tumors that have a mutation in the ARID1A gene. The study includes patients with platinum-resistant ovarian clear cell carcinoma, endometrial cancer that failed immunotherapy, and other tumo…
Phase 2 • Sponsor: Tarapeutics Science Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Promising combo aims to shrink bladder tumors before surgery
Disease control Not yet recruitingThis study tests whether combining two drugs (trastuzumab rezetecan and camrelizumab) before surgery can improve outcomes for people with a certain type of muscle-invasive bladder cancer (HER2-positive). About 44 adults will receive the treatment to see if it helps eliminate canc…
Phase 2 • Sponsor: Sheng Tai • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could immune cells tame advanced bladder cancer? early trial aims to find out
Disease control Not yet recruitingThis early study will test a new type of immune cell therapy in 20 people with advanced bladder cancer that hasn't responded to standard treatments. The therapy uses the patient's own γδ-T cells, which are grown in a lab and then infused back to attack the cancer. The main goal i…
Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Bladder cancer: can faster chemo before surgery boost cure rates?
Disease control Not yet recruitingThis phase 2 trial tests a dose-dense (faster) schedule of two chemotherapy drugs, gemcitabine and cisplatin, given before surgery for muscle-invasive bladder cancer. The goal is to see if this approach can completely eliminate the tumor in the bladder and lymph nodes. Thirty eli…
Phase 2 • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 26, 2026 19:10 UTC
-
Cannabis gummies aim to ease Post-Surgery recovery for bladder cancer patients
Symptom relief Not yet recruitingThis early-stage study will give 20 bladder cancer patients cannabigerol (CBG) gummies before and after surgery to see if they are safe and tolerable. The goal is to improve quality of life and reduce symptoms during recovery. Researchers will monitor side effects and how well pa…
Early phase 1 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Morning or afternoon? new study tests best time for bladder cancer drugs
Symptom relief Not yet recruitingThis study looks at whether giving standard bladder cancer drugs in the morning or afternoon changes how well they work and how many side effects they cause. About 224 adults with advanced bladder cancer will be randomly assigned to receive their treatment either before 11:30 a.m…
Phase 3 • Sponsor: Guliz Ozgun • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC